Report

This Global Alliance for TB Drug Development (TB Alliance) report contains portfolio updates, team information, and project summaries on their research for new TB drugs.

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies from Indonesia, Mexico, Sierra Leon, South Africa, Ukraine, and the Caribbean, highlighting community advocates’ strategies, achievements, and lessons learned.

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

During November 2004 - November 2005, CDC and WHO surveyed an international network of TB laboratories to assess the frequency and distribution of extensively drug-resistant (XDR) TB cases. This report summarizes the results of that survey.

As a result of the first meeting of the Global XDR TB Task Force (October 6-7, 2006), the case definition of extensively drug-resistant tuberculisis (XDR TB) was revised. This Notice to Readers details the events leading up to this revision and the new case definition.